share_log

亞盛醫藥-B:自願公告 - 亞盛醫藥奧雷巴替尼及APG-2575的多項臨床進展將在2023年美國血液學會年會(ASH)展示,其中兩項獲口頭報告

ASCENTAGE-B: Voluntary Announcement - Ascentage Pharma to Present Results from Multiple Clinical Studies of olverembatinib and APG-2575 at the 2023 American Society of Hematology (ASH) Annual Meeting, two of which have been Selected for Oral Reports

香港交易所 ·  Nov 2, 2023 19:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more